Overcoming Chemoresistance via an AIEgen-Based Covalent Organic Framework
An Song1,2, Qing Wang1, Bo-Yu Liu3
1State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Frontier Science Center for Immunology and Metabolism, Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan 430079, China.
Abstract:
Chemoresistance remains a major barrier to effective cancer treatment, leading to tumor recurrence and high mortality. Developing strategies to combat chemoresistant tumors is therefore an urgent challenge. Here, we report a covalent organic framework (COF) nanomedicine, 3N-DPQ-COF, designed to target chemoresistant cancers. Mechanistic studies reveal that 3N-DPQ-COF accumulates efficiently in resistant tumor cells and suppresses cancer stemness in 4T1 and CT26 models, outperforming doxorubicin. Moreover, 3N-DPQ-COF promotes CD8+ T-cell infiltration and reduces the number of immunosuppressive erythroid progenitor cells and myeloid-derived suppressor cells, thereby remodeling the tumor microenvironment (TME) and inducing GSDME-dependent pyroptosis. Remarkably, even without checkpoint blockade, 3N-DPQ-COF suppresses metastasis and recurrence in chemoresistant 4T1 tumors, achieving >90% tumor inhibition and cure rates exceeding 80%. This study highlights the potential of AIEgen-based COF nanomedicines for overcoming chemoresistance through concurrent modulation of tumor stemness, pyroptosis, and immune activation.
Insights
A novel covalent organic framework (COF) nanomedicine effectively targets chemoresistant cancers by suppressing cancer stemness and immune suppression. This breakthrough nanomedicine shows significant potential for treating recurrent tumors and improving patient outcomes.
Area of Science:
- Biomedical Engineering
- Materials Science
- Cancer Research
Background:
- Chemoresistance is a significant obstacle in cancer therapy, leading to treatment failure, tumor recurrence, and increased mortality.
- Effective strategies are urgently needed to overcome chemoresistance and improve patient survival rates.
Purpose of the Study:
- To develop and evaluate a novel covalent organic framework (COF) nanomedicine, 3N-DPQ-COF, for targeting and treating chemoresistant cancers.
- To investigate the mechanisms by which 3N-DPQ-COF overcomes chemoresistance, including its effects on cancer stemness, the tumor microenvironment (TME), and immune activation.
Main Methods:
- Synthesis and characterization of the AIEgen-based COF nanomedicine, 3N-DPQ-COF.
- In vitro and in vivo evaluation of 3N-DPQ-COF in chemoresistant 4T1 and CT26 cancer models.
- Assessment of 3N-DPQ-COF's impact on cancer stemness, TME composition (CD8+ T cells, myeloid-derived suppressor cells, erythroid progenitor cells), and pyroptosis induction (GSDME-dependent).
Main Results:
- 3N-DPQ-COF demonstrated efficient accumulation in resistant tumor cells and suppressed cancer stemness, outperforming doxorubicin in 4T1 and CT26 models.
- The nanomedicine promoted CD8+ T-cell infiltration, reduced immunosuppressive cells, and induced GSDME-dependent pyroptosis, effectively remodeling the TME.
- Remarkably, 3N-DPQ-COF suppressed metastasis and recurrence in chemoresistant tumors, achieving over 90% tumor inhibition and cure rates exceeding 80% without checkpoint blockade.
Conclusions:
- AIEgen-based COF nanomedicines, exemplified by 3N-DPQ-COF, offer a promising strategy for overcoming chemoresistance.
- Concurrent modulation of tumor stemness, pyroptosis, and immune activation by 3N-DPQ-COF presents a potent approach for cancer treatment.
- This study underscores the therapeutic potential of advanced nanomedicines in addressing critical challenges in oncology, including metastasis and recurrence.
More Related Videos
Related Concept Videos
Covalent Bonds
Covalent Bonds
When two atoms share electrons to complete their valence shells, they create a covalent bond. An atom's electronegativity—the force with which shared electrons are pulled towards an atom—determines how the electrons are shared. Molecules formed with covalent bonds can be either polar or nonpolar. Atoms with similar electronegativities form nonpolar covalent bonds; the electrons are shared equally. Atoms with different electronegativities share electrons unequally,...
Network Covalent Solids
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Covalently Linked Protein Regulators
Covalent Bonding and Lewis Structures


